Question 20: XXX XXXXXXX care XX sees a XXX African-American patient XXX has blood XXXXXXXX readings XX 140/90 mm Hg, 130/XX mm XX, and 142/XX mm Hg on XXXXX XXXXXXXX occasions. The XX XXXXXX that XXX XXXXXXX XXX a family XXXXXXX XX XXXXXXXXXXXX. XXX XX should:
a. initiate monotherapy XXXX a thiazide XXXXXXXX. b. prescribe a thiazide XXXXXXXX XXX an angiotensin-converting enzyme XXXXXXXXX. c. XXXXXXX dietary XXX XXXXXXXXX XXXXXXXXXXXXX XXXX XXX XXXXXXX. d. begin combination XXXXXXX with an XXX and a XXXXXXX-channel XXXXXXX.
Question 21: An African-American patient is XXXXXX XXXXXXXXX (Capoten) 25 mg twice XXXXX. When performing a XXXXXXXX XXXXXXXXXXX, the primary care XXXXX XXXXXXXXXXXX (NP) XXXXXX that the XXXXXXX continues to XXXX XXXXX pressure XXXXXXXX of XXX/90 mm Hg. XXX NP should:
a. increase XXX captopril dose to 50 mg twice XXXXX. b. add a thiazide XXXXXXXX to this XXXXXXX's regimen. c. change XXX drug XX losartan (XXXXXX) XX XX once daily. d. recommend a XXX-sodium diet in XXXXXXXX to XXX XXXXXXXXXX.
Question 22: X patient who has a XXXXXXX of XXXXXXX XXXXXXXXXXXX XXXX a bulk XXXXXXXX to prevent episodes of acute XXXXXXXXXXXX. XXX XXXXXXX reports having an increased frequency XX XXXXXXXX. XXX XXXXXXX care NP XXXXXX XXXXXXXXX:
a. adding XXXXXXXX sodium (Colace).
b. polyethylene XXXXXX (XXXXXXX) and XXXXXXXXX (Dulcolax).
c. lactulose (XXXXXXXXX) XXX XXXXXXXXXXXX XXXXXX (XXXXXXX).
d. adding XXXXXXXXXXXXXXXX XXXXXXXX such XX biofeedback
XXXXXXXX 23: X woman with IBS has been taking antispasmodic XXXXXXXXXXX XXX XXXXXXX XXXX relief, but XXX XXXXX XXX primary XXXX NP XXXX XXX XXXXXXX XX interfering with her XXXXXXX XX work because XX increased pain. XXX NP should XXXXXXXX prescribing:
a. alosetron (XXXXXXXX). b. XXXXXXXXXXX (XXXXXXX). c. simethicone (XXXXXXX). d. XXXXXXXXX XXXXXXXXXXXXXXX (XXXX).
XXXXXXXX 24: A XX-XXXX-XXX woman XXX not XXX menstrual XXXXXXX XXX 5 years XXX tells XXX primary XXXX XXXXX XXXXXXXXXXXX (XX) XXXX she XX having XXXXXXXXXXXX frequent XXXXXXXXX symptoms. She XXX no family history or XXXX factors XXX coronary heart disease (CHD) or breast XXXXXX but XX concerned about these XXXX effects of hormone therapy (XX). XXX XX should:
a. XXXX her XXXX starting HT XXX XXX reduce her XXXX XX XXXXXX cancer. b. XXXXXX a short course of XX now that XXX XXXXXXXX her XXXX for XXX. c. tell her that HT will XXX XXXX XXXXXXX her XXXXXXXX XXXXXX XXXXXXXXXXXXX. d. XXXXXXXXX XXXXXX XXXXXXXXXXX for her XXXXXXXX to XXXXX XX side effects.
Question XX: A XXXXXXX XXX XXX XXXXXX fibrillation (AF) has XXXX taking XXXXXXXX (XXXXXXXX). XXX XXXXXXX care XXXXX XXXXXXXXXXXX (XX) XXXXX to XXXXXX XXX patient’s medication to dabigatran (Pradaxa). XX do this XXXXXX, XXX NP XXXXXX:
a. initiate XXXXXXXXXX XXXX XXX XXXXXXX's XXXXXXXXXXXXX normalized ratio (XXX) is less XXXX X. b. start dabigatran X to XX days after discontinuing warfarin. c. XXXXX XXXXXX dabigatran X XXXX XXXXXX discontinuing warfarin. d. order frequent XXXXXXXXXX of XXX patient's INR after XXXXXXXXXX therapy begins.
Question XX: A XX-year-XXX patient XXX has a positive family history XXX no personal history of coronary XXXXXX disease XX seen by XXX XXXXXXX XXXX NP for a XXXXXXXX XXXXXXXXXXX. XXX XXXXXXX XXX a body mass index XX 27 XXX a blood pressure XX 130/XX mm XX. XXXXXXXXXX tests reveal low-density XXXXXXXXXXX, XXX mg/XX; high-XXXXXXX lipoprotein, 70 mg/XX; XXX triglycerides, XXX mg/dL. The XXXXXXX does XXX XXXXX but XXX a sedentary lifestyle. XXX NP should recommend:
a. 30 XXXXXXX of aerobic exercise daily. b. taking XX XX XXX mg of XXXXXXX daily. c. XXXXXXXXX XXXXXXX XXXX a XXXXXX XXXXXXXXXX. d. XXXXXXXX a thiazide XXXXXXXX XX XXXXX XXXXXXXXXXXX.
Question XX: X XXXXXXXX active patient tells the primary care NP XXXX XXX XXX been unable XX XXX her XXX COCP pill XXXX XXXXX today XXX XXX missed X days of pills. XXX XX should XXXX her XX:
a. use XXXXXX XXXXXXXXXXXXX XXX XXXX X pills XXXX day for XXX XXXX 2 days. b. XXXXX a new XXXX XX XXXXX XXXXX and use backup contraception for 7 XXXX. c. XXXXX a XXX pack of pills XXXXX, XXXX a Plan X pill, and XXX XXXXXX contraception for 7 XXXX. d. Take a XXXXXXXXX test, begin a XXX pack XX pills today, XXX XXX backup contraception for X XXXX.
Question 28: A patient XXX XXX insulin-XXXXXXXXX type 2 diabetes reports XXXXXX difficulty XXXXXXX blood XXXXXXX XXXXXX XXXXXX XXXXXX XXX XXX had XXXXXXXX episodes of both XXXXXXXXXXXX XXX XXXXXXXXXXXXX. As adjunct XXXXXXX XX XXXXXX this problem, the primary XXXX XX should prescribe:
a. XXXXXXXXXXX (XXXXXX). b. XXXXXXXXXXX (Prandin). c. XXXXXXXXX (Micronase). d. metformin (Glucophage).
Question XX: The XXXXXXX XXXX NP XXXX a new patient XXX a routine physical examination. XXXX auscultating the heart, the NP XXXXX a XXXXX XXXX XX XX XXXXX XXX XXXXXX XXXX XXXXXXXXXX XXXXX beats XXXXXXXX XX a XXXXX. XXXXXXX XXXXXXX no XXXX XXXXXXXXXXXXXX XXXXXXX, but XXX XXXXXXX reports occasional syncope XXX shortness of XXXXXX. The NP should:
a. order an ECG XXX XXXXX to a XXXXXXXXXXXX. b. schedule a XXXXXXX XXXXXX XXXX XXX a XXXXXX exercise XXXX. c. order a XXXXXXXX blood count (CBC) XXX electrolytes and XXXXXXXX a XXXXX of XXXXXXXXXXXX. d. prescribe a B-XXXXXXX XXX anticoagulant and order 24-XXXX XXXXXX monitoring.
XXXXXXXX 30: A XXXXXXX XXX has XXXXXXXX XXXXXXXXX has begun taking XXXXXXX and X XXXXXX XXXXX beginning XXXX XXXXXXX XXXXXXX XX change in frequency XX XXXXXXXXX. The XXXXXXX’s current dose XX XX XX once XXXXX. The XXXXXXX XXXX XX should:
a. change XXX XXXXXXXXXX to XXXXXXXXXXX. b. XXXXXXXX the XXXX to 40 XX once XXXXX. c. obtain XXXXX drug XXXXXX XX XXX XX the XXXX is XXXXXXXXXXX. d. tell the patient to continue XXXXXX XXX timolol XXX XXXXXX in 1 month.
Question XX: A XXXXXXX who XXX breast cancer has been taking XXXXXXXXXX for 2 XXXXX. She XXXXX her primary care NP XXXX XXX XXXXXX her tumor XXX XXXXX XXXXXX. XXX NP XXXXXX:
a. XXXXXXXX her for a breast ultrasound. b. XXXXXXXX her XXXX this XX common and will XXXXXXX. c. XXXX her she may need an XXXXXXXXX XXXX XX this medication. d. XXXXXXX her oncologist XX XXXXXXX adding XXXXXXX XXXXXXXXXX.
Question 32: A CNM:
a. may treat XXXX women. b. XXX XXXXXXXXXXXX XXXXXXXXX in XXX XX XXXXXX. c. XXX administer XXXX XXXXX used XXXXXX XXXXX XXX delivery. d. XXX XXXXXXXX only in birthing XXXXXXX XXX XXXX birth settings.
Question 33: XXX XXXXXXX XXXX NP XX preparing to XXXXXXXXX a diuretic for a patient who has XXXXX XXXXXXX. The XXXXXXX XXXXXXX having had an XXXXXXXX XXXXXXXX XX XXXXXXXXXXXXXXXX-XXXXXXXXXXXX (Bactrim) previously. The XX XXXXXX prescribe:
a. XXXXXXXXXX acid. b. furosemide (Lasix). c. acetazolamide (Diamox). d. hydrochlorothiazide (XXXXXXXXXXX).
Question XX: In every state, prescriptive authority XXX XXX XXXXXXXX XXX ability XX XXXXX prescriptions:
a. for XXXXXXXXXX XXXXXXXXXX. b. XXX specified XXXXXXXXXXXXXXX XX XXXXXXXXXXX. c. without physician-mandated XXXXXXXXXXX. d. with XXXX, independent prescriptive authority.
XXXXXXXX XX: XXX XXXXXXX care NP is seeing a patient for a hospital XXXXXX-up XXXXX the XXXXXXX XXX had a first XXXXXXXXXX XXXXXXXXXX. XXX patient XXX a list of XXX XXXXXXXXXX XXXXXXXXXXX and tells XXX XX XXXX “XX one explained XXXXXXXX XXXXX them.” XXX NP’s XXXXXXX XXXXXXXX should XX to:
a. ask XXX patient XX describe the medication XXXXXXX. b. XXX the XXXXXXX XX make a list XX XXXXXXXXX about the XXXXXXXXXXX. c. determine XXXX the XXXXXXX understands XXXXX coronary XXXXXX disease. d. give the patient information XXXXX XXXX effects XXX any XXXXXXX XXXXXXXXX.
Question XX: X XXXXXXX XXXX XXXXXXX hypercholesterolemia XX taking an XXX-XXX reductase inhibitor. All XX the XXXXXXX’s XXXXXXXX XXXX were normal. XX a X-XXXXX XXXXXX-up visit, the patient reports XXXXXXXXXX headache. X lipid profile reveals a decrease XX 20% in XXX patient’s LDL XXXXXXXXXXX. The XX XXXXXX:
a. order LFTs. b. order CK-XX tests. c. consider XXXXXXXXXX the dose of the XXXXXXXXXX. d. reassure the XXXXXXX that XXXX side effect is XXXXXX.
XXXXXXXX XX: A XXXXXXX receives an inhaled XXXXXXXXXXXXXX to treat asthma. XXX patient XXXX the XXXXXXX care NP XXX the XXXX XX given by this XXXXX XXXXXXX XX orally. XXX XX XXXXXX XXXXXXX that the inhaled XXXX:
a. XX absorbed less quickly. b. XXX XXXXXXX XXXXXXXXXXXXXXX. c. has XXXXX XXXXXXXX side XXXXXXX. d. XXXXXXXX dosing XXXX is easier XX regulate.
Question 38: XXX primary XXXX nurse XXXXXXXXXXXX (XX) XXXX a XXXXXXX for a physical XXXXXXXXXXX and XXXXXX XXXXXXXXXX tests that reveal low-density XXXXXXXXXXX (XXX) of 100 mg/dL, high-XXXXXXX XXXXXXXXXXX (XXX) of 30 mg/dL, XXX XXXXXXXXXXXXX of 350 mg/dL. The XXXXXXX has no previous history XX XXXXXXXX heart XXXXXXX. The NP should XXXXXXXX XXXXXXXXXXX:
a. ezetimibe (Zetia). b. gemfibrozil (Lopid). c. simvastatin (Zocor). d. nicotinic XXXX (XXXXXXX).
Question XX: X XXXXX XXX is taking a progestin-XXXX pill XXX XXXX stopped nursing her 9-month-old infant and tells the primary care XX that she would like XX XXXXX her children XXXXX X XXXXX XXXXX. XXX XX XXXXXX:
a. discontinue the XXXXXXXXX-XXXX XXXX. b. XXXXXXXXX a COCP XXX a XXXXX XXXX supplement. c. prescribe a progestin-only pill XXX XXXXXXX X XXXXXX. d. suggest XXXX XXX use a barrier XXXXXX XX XXXXXXXXXXXXX.
Question 40: X XXXXXXX care XX XXXX a X-year-XXX XXXXXXX who has been XXXXXXXX for several XXXX. The child has XXX fewer XXXXXXXX XX vomiting the past XXX and XX XXX able XX XXXX XXXX of fluids XXXXXXX vomiting. The child has XXX XXXX mucous XXXXXXXXX, 2-XXXXXX capillary XXXXXX, XXX pale XXX XXXX skin. XXX child’s blood pressure XX 88/XX XX XX, XXX XXXXX XXXX XX 110 beats XXX minute, XXX XXX temperature is 37.2° C. The NP XXXXXX:
a. XXXXXXXXX XXXXXXXXXXXX. b. prescribe a scopolamine XXXXX. c. begin XXXX rehydration therapy. d. send the XXXXX to XXX hospital XXX XX fluids.
XXXXXXXX 41: X XXXXXXX has been XXXXX an XXXXXX supplement for 2 XXXXX that the XXXXXXX care XX XXXXX may have XXXXX XXXX XXXXXXX. The XX XXXXXX:
a. tell XXX patient to XXXX taking XXX supplement immediately. b. XXXXXX the XXXXXXX of the risks XX toxic XXXX XXXXXXX XXXX this supplement. c. XXXXX XXX patient to a CAM provider who can manage XXXX XXXXXXX's therapy. d. XXXXXXXXX another herbal drug that has fewer adverse effects than XXX one XXX XXXXXXX is taking.
Question XX: An XX-XXXX-old XXXXXXX who XXX XXXXXXXXXX XX takes warfarin (Coumadin) XXX anticoagulation XXXXXXX. The patient XXX an INR XX X.5. The primary XXXX NP should XXXXXXXX:
a. XXXXXXXX XXX XXXX XX warfarin. b. rechecking the INR in 1 XXXX. c. omitting a XXXX XXX resuming XX a XXXXX XXXX. d. omitting a XXXX and XXXXXXXXXXXXX 1 mg of XXXXXXX X.
XXXXXXXX XX: X patient XX in the clinic complaining of nausea and vomiting XXXX has XXXXXX X to 3 days. XXX patient has dry oral mucous XXXXXXXXX, a XXXXX XXXXXXXX XX 90/XX XX XX, a XXXXX XX 96 XXXXX XXX minute, and a temperature XX 38.X° X. The XXXXXXX XXXX XX XXXXX a XXXXXXXXX XXXXXX of XXXXXXX than 3 XXXXXXX. XXX XX should:
a. obtain a XXXXXXXX XXXXX count XXX serum electrolytes. b. XXXXXXXXX a rectal antiemetic medication. c. admit to the XXXXXXXX XXX XXXXXXXXXXX (IV) rehydration. d. encourage the XXXXXXX to XXXX small, frequent sips of XXXXXXXX.
Question XX: X XXXXXXX XXXX a primary care XX whether over-the-XXXXXXX XXXXX are XXXXX than prescription drugs. The NP XXXXXX XXXXXXX XXXX over-the-counter drugs are:
a. XXXXXXXXX XXXX when label XXXXXXXXXXX is XXXXXXXXXX and XXXXXXXX. b. XXXXX XXXXXXX over-XXX-XXXXXXX XXXXX are XXXXX XXXX prescription XXXXX XX XXX same drug. c. XXXX safe XXXXXXX they XXX not well XXXXXXXXX by XXX XXXX XXX XXXX Administration (FDA). d. XXX extensively XXXXXX, so XXXXXX made XX manufacturers cannot be XXXXXXXXXXXXX.
Question 45: X patient XXX XXXX XXXXXX levothyroxine XXX mcg XXXXX XXX several XXXXXX. XXX patient XXXXX to the XXXXXX with complaints of XXXXXXXX XXX irritability. The XXXXXXX care NP XXXXX a heart XXXX of 92 XXXXX XXX minute. The XX XXXXXX:
a. XXXXXX XX XXXXXXXXXXXX 75 XXX/day. b. discontinue XXXXXXXXXXXXX XXXXXXXXXXXX. c. order XXXXXXXXXXXXXXXX XX XXXXXXX XXX XXXXXXXXX XXXXXXX XXXXXX. d. order XXX XXX XX levels and decrease the dose to 75 XXX/day.
XXXXXXXX XX: X XXXXXXX who has XXXXXX XXX who XX known to XXX XXXXXXX care NP calls the XX XXXXX XXXXX XXX asks for a refill of an XXXXXXXXX metered-XXXX XXXXXXX. The XXXXXXX has not XXXX XXXX in the clinic for more than a XXXX. XXX NP should:
a. XXXX the XXXXXXXX XX order the medication with XXXXXXX XXXXXXX. b. send an electronic prescription XX XXX pharmacy for one time only. c. XXXX XXX XXXXXXX XX XXX XXXXXXXXX XXXXXXXXXX XXX evaluation of XXXXXXXX. d. refill the drug and XXXX XXX patient that an XXXXXX XXXXX is XXXXXXXXX XXX further XXXXXXX.
XXXXXXXX XX: X patient XXXXX to know why a cheaper XXXXXXX XX a XXXX cannot be used XXXX XXX primary care NP writes a XXXXXXXXXXXX XXX a specific XXXXX XXXX of XXX drug and writes, “Dispense XX Written.” XXX XX should explain XXXX a different XXXXX of XXXX drug:
a. XXX cause XXXXXXXXX adverse effects. b. XXXX not necessarily have the XXXX therapeutic effect. c. XX likely XX XX less safe XXXX XXX brand specified in the XXXXXXXXXXXX. d. may XXXX in the XXXXXX of XXXX that XXXXXXX XXX site of XXXXXX in the body.
XXXXXXXX XX: X XXXXXXX XXX has XXXXXXXXXX heart failure and XXXXXXXXX XXX XXXX XXXXXX chlorthalidone (Zaroxolyn) 25 mg XXXXX for 6 months. The primary care NP XXXXX a XXXXXXXXXX blood XXXXXXXX XX XXX/90 mm Hg. The NP XXXXXX:
a. ask XXX XXXXXXX which XXXXXXXXXXX XXX XXXX XXX XXXX. b. add furosemide (Lasix) XX the patient's drug XXXXXXX. c. increase the dose of XXXXXXXXXXXXXX to 100 mg XXXXX. d. recommend XXXX XXX XXXXXXX XXX salt substitutes XX XXXXXX foods.
Question 49: XXX XXXXXXX XXXX XX XXXX a XXXXXXX XXX has a XXXXXXX of XXXXXXXXXXXX and XXXXXXXXXX. The XXXXXXX is not XXXXXX any XXXXXXXXXXX. XXX XX auscultates XXXXXXXX in both lungs XXX palpates the liver X XX below the costal margin. Laboratory tests show an elevated creatinine level. XXX NP will refer XXXX patient XX a cardiologist XXX should prescribe:
a. albuterol metered-XXXX inhaler. b. furosemide (Lasix). c. spironolactone (Aldactone). d. chlorthalidone (Zaroxolyn).
Question 50: X XXXXXXX XXXX chronic XXXX XXXX XXXX XX unrelieved by XXXXXXXXXXXX analgesic medications XXXX a XXXXXXX XXXX nurse XXXXXXXXXXXX (NP) about XXXXXXXXXXX treatments. XXX XX XXXXXX XXXX this XXXXXXX:
a. XXXXXXXX therapy XXX been XXXXX XX XX XXXX XXXXXXXXX XXXX XXXXXXXXXXX. b. XXXXXXXX XXX been XXXXX to be an XXXXXXXXX herbal choice to XXXXX XXXX pain. c. XXXXX XX no valid XXXXXXXX XXXXXXXXXXX the efficacy of XXXX treatment XXX XXXX. d. XXXX XXXXXXX that show XXXXXXXX of alternative XXXXXXXXX XXX XXXXX XX observation.
Question XX: A patient XXXX XXXXXXXXXX XXXXX failure XXXX begin XXXXXXX with a diuretic XXXXXXXXXX. The primary care NP orders XXXXXXXXXX XXXXX, XXXXX XXXXXX a XXXXXXXXXX filtration XXXX (GFR) XX XX mL/minute. XXX XXXXXXX XXXX XXX NP should prescribe is:
a. XXXXXXXXXX. b. furosemide (XXXXX). c. spironolactone (XXXXXXXXX). d. hydrochlorothiazide (XXXXXXXXXXX).
XXXXXXXX 52: The XXXXXXX XXXX NP sees a XXXXXXX several months XXXXX a XXXXXXXXXX infarction (MI). XXX patient XXX been taking furosemide XX XXXXX heart failure. The XX notes that the XXXXXXX XXX edema XX XXX XXXXX, feet, XXX XXXXXX. XXX NP XXXXXX add which XXXX to XXXX patient’s XXXXXXX?
a. Ethacrynic XXXX b. Chlorothiazide (XXXXX) c. XXXXXXXXXXX (Dyrenium) d. XXXXXXXXXXXXXX (XXXXXXXXX)
Question 53: An important XXXXXXXXXX between XXXXXXXXX assistants (PAs) XXX NPs is XXX:
a. always work under physician XXXXXXXXXXX. b. are XXX XXXXXXXX to follow XXXX treatment protocols. c. may XXXXX for XXX XXXX categories XXXX physician co-XXXXXXXXXX. d. have both inpatient and XXXXXXXXXX XXXXXXXXXXX XXXXXXXXXXXX authority.
XXXXXXXX XX: X XXXXXXX care NP XX XXXXXXXXXX a handout to give XX patients who XXXX begin self-XXXXXXXXXXXXX insulin. XXXX developing this XXXXXXX, the NP should:
a. XXXXXXX detailed XXXXXXXXXXXX of XXXX XXXX in XXX process of XXXXXXXXX XXXXXXX. b. XXX correct medical XXXXXXXXXXX when XXXXXXXXXX XXXXXXX XXXX-XXXXXXXXXXXXXX. c. XXXXXXX as much XXXXXXX information as XXXXXXXX XXXXX insulin administration. d. address one or XXX XXXXXXXXXXX objectives XXXX describe what XXX XXXXXXX XXXX learn.
Question 55: XX XX-year-XXX XXXXXXX has XXXXX taking propranolol (Inderal) and XXXXXXX feeling tired all XX XXX time. The XXXXXXX XXXX NP XXXXXX:
a. XXXX the XXXXXXX XX XXXX taking XXX medication immediately. b. recommend XXXX the patient take the XXXXXXXXXX at bedtime. c. XXXX the XXXXXXX that XXXXXXXXX to XXXX side XXXXXX will XXXXX XXXX time. d. XXXXXXX the patient's cardiologist to XXXXXXX decreasing the dose XX propranolol.
Question 56: An 80-XXXX-old male patient will begin taking an B-XXXXXXXXXXXXXX XXXXXXXXXX. The XXXXXXX XXXX XX XXXXXX teach this XXXXXXX to:
a. XXX for assistance while XXXXXXX. b. restrict XXXXXX to aid with XXXXXXXX. c. take the medication in XXX XXXXXXX XXXX food. d. XX aware XXXX XXXXXXXX is a common side effect.
XXXXXXXX XX: A XXXXX XXX uses a transdermal XXXXXXXXXXXXX calls XXX primary care XX XX report XXXX XXXXX dressing that morning she discovered XXXX XXX XXXXX had XXXX XXX and she XXX XXXXXX XX XXXX XXX XXXXX. XXX NP XXXXXX XXXX her XX apply a new XXXXX XXX:
a. take XXX XXXXX XX XXXXX. b. XXXX a XXXX XXXXXXXXX XXXX. c. use XXXXXXX XXX XXX XXXX X XXXX. d. XXXXXXX XXX clinic if XXX misses a XXXXXX.
XXXXXXXX 58: X XXXXX XXX XXX been taking a XXXX tells XXX XXXXXXX care NP that, XXXXXXX XX XXXXXXXX XXXXXXX in her work schedule, XXX has XXXXXXXXXX remembering XX XXXX her XXXXX. The woman XXX XXX NP decide to change to a XXXXXXX ring. XXX XX XXXX XXXXXXXX her XX XXXXXX XXX ring:
a. within X days after her last XXXXXX pill. b. and XXX a backup contraceptive for 7 XXXX. c. and continue XXX COCP XXX XXX XXXX XXXXX. d. on XXX XXXX day XXX XXXXX XXXXXX her XXXX.
XXXXXXXX XX: X XX-XXXX-old XXXXXXX has acute diarrhea XXX an XXXXX XXXXXXXXXXX infection. Other family members have XXX XXXXXXX XXXXXXXX, XXXXX have XXXXXXXX. XXX XXXXXXX XXXX XX should XXXXXXXXX:
a. XXXXXXXXXXXXX (Lomotil). b. attapulgite (Kaopectate). c. an XXXXXXXXXXX XXXXXXXX (XXXXXXXXX). d. XXXXXXX subsalicylate (XXXXX-Bismol).
Question 60: X XXXXXXX is taking drug X and XXXX B. The primary care XX XXXXX increased effects of XXXX B. XXX XX XXXXXX suspect that in this case XXXX A XX a cytochrome P450 (CYP450) enzyme:
a. XXXXXXXXX.
b. XXXXXXXXX.
c. inducer.
d. metabolizer